Furthermore, research conducted by Li et al. demonstrated that FEN1 inhibitors can enhance the sensitivity of cervical cancer cells to radiotherapy [51], while Mesquita et al. found that FEN1 inhibitors increase cisplatin sensitivity in ovarian cancer cells [15]. This evidence concerns the gene FEN1 and cervical carcinoma.